Cargando…

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma

Icaritin is a potential treatment option for hepatocellular carcinoma (HCC) based on the results of its phase 2 stage trial. Glucose transporter 1 (GLUT1), a critical gene in regulating glycolysis, has been recognized as a promising target in HCC treatment. Previous studies have reported that FAM99A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Xia, Gou, Yudong, Jiang, Ziyu, Yang, Aizhen, Yang, Zhihui, Qin, Shukui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576446/ https://www.ncbi.nlm.nih.gov/pubmed/34765550 http://dx.doi.org/10.3389/fonc.2021.740557

Ejemplares similares

Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
por: Li, Shasha, et al.
Publicado: (2013)

Icaritin suppresses multiple myeloma, by inhibiting IL-6/JAK2/STAT3
por: Zhu, Shicong, et al.
Publicado: (2015)

A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway
por: Zhao, Hong, et al.
Publicado: (2015)

Mechanism of action of icaritin on uterine corpus endometrial carcinoma based on network pharmacology and experimental evaluation
por: Jin, Yan-Bin, et al.
Publicado: (2023)

Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2022)

Epirubicin Enhances the Anti-Cancer Effects of Radioactive (125)I Seeds in Hepatocellular Carcinoma via Downregulation of the JAK/STAT1 Pathway
por: Guo, Lei, et al.
Publicado: (2022)

MiR-365a-3p-Mediated Regulation of HELLS/GLUT1 Axis Suppresses Aerobic Glycolysis and Gastric Cancer Growth
por: Yang, Rui, et al.
Publicado: (2021)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
por: Bousoik, Emira, et al.
Publicado: (2018)

BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1
por: Wang, Peng, et al.
Publicado: (2023)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2022)

JAK/STAT signaling in hepatocellular carcinoma
por: Hin Tang, Justin Jit, et al.
Publicado: (2020)

β-Boswellic Acid Suppresses Breast Precancerous Lesions via GLUT1 Targeting-Mediated Glycolysis Inhibition and AMPK Pathway Activation
por: Bie, Fengjie, et al.
Publicado: (2022)

Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
por: Xue, Zhong, et al.
Publicado: (2023)

Integrated Analysis of FAM57A Expression and Its Potential Roles in Hepatocellular Carcinoma
por: Wei, Junwei, et al.
Publicado: (2021)

Icaritin Reduces Oral Squamous Cell Carcinoma Progression via the Inhibition of STAT3 Signaling
por: Yang, Jian-Guang, et al.
Publicado: (2017)

Icaritin Inhibits Migration and Invasion of Human Ovarian Cancer Cells via the Akt/mTOR Signaling Pathway
por: Gao, Lvfen, et al.
Publicado: (2022)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway
por: Nie, Qian, et al.
Publicado: (2021)

A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
por: Li, Haowen, et al.
Publicado: (2020)

Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings
por: Zhu, Jian feng, et al.
Publicado: (2011)

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
por: Xia, Xigang, et al.
Publicado: (2021)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway
por: Zhao, Qi, et al.
Publicado: (2021)

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
por: Manore, Sara G., et al.
Publicado: (2022)

Integrated systemic analysis of FAM72A to identify its clinical relevance, biological function, and relationship to drug sensitivity in hepatocellular carcinoma
por: Zhou, Qi, et al.
Publicado: (2022)

Activating JAK1 mutation may predict the sensitivity of JAK-STAT inhibition in hepatocellular carcinoma
por: Yang, Shuqun, et al.
Publicado: (2015)

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
por: Olschok, Kathrin, et al.
Publicado: (2023)

Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma
por: Pan, Yu, et al.
Publicado: (2021)

CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis
por: Chen, Zhimin, et al.
Publicado: (2022)

Long noncoding RNA SLC2A1‐AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway
por: Shang, Runze, et al.
Publicado: (2020)

Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
por: Dong, Peixin, et al.
Publicado: (2022)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

DHHC9-mediated GLUT1 S-palmitoylation promotes glioblastoma glycolysis and tumorigenesis
por: Zhang, Zhenxing, et al.
Publicado: (2021)

Pharmacokinetics and metabolism of icaritin in rats by UPLC‐MS/MS
por: Huang, Zhen‐Wu, et al.
Publicado: (2019)

Chronic Stress Activates PlexinA1/VEGFR2-JAK2-STAT3 in Vascular Endothelial Cells to Promote Angiogenesis
por: Lu, YanJie, et al.
Publicado: (2021)

STAT3 Promotes Invasion and Aerobic Glycolysis of Human Oral Squamous Cell Carcinoma via Inhibiting FoxO1
por: Zheng, Min, et al.
Publicado: (2019)

The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/Stat 5/β-Catenin Signaling Pathway
por: Liao, Jinrong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vm4tlu4ksq2s9vh5dpjnpvean2